Azioni Biotie Therapies Corp

Azioni

Tempo differito Nasdaq Helsinki Altri mercati azionari			Variaz. 5gg	Var. 1 gen.
- ^EUR	-.--%		-.--%	-.--%

Durata

Periodo

Stile

Biotie Therapies : ACORDA GAINS TITLE TO BIOTIE SHARES AND THE SHARES WILL DELIST	30/09/16
Biotie Therapies : ARBITRAL TRIBUNAL CONFIRMED ACORDA'S REDEMPTION RIGHT REGARDING BIOTIE SHARES AND BIOTIE SHARES TRADING HAS BEEN TERMINATED	26/09/16
Biotie: BTT1023 receives Orphan Drug Designation in the United States	26/08/16
Biotie Therapies : THE LISTING COMMITTEE OF NASDAQ HELSINKI HAS RESOLVED TO DELIST THE SHARES OF BIOTIE THERAPIES CORP.	25/08/16
Biotie Therapies : CORP. APPLIES FOR DELISTING OF ITS SHARES FROM NASDAQ HELSINKI	18/08/16

Dirigenti	Titolo	Età	Da
Antero Kallio CEO	Chief Executive Officer	64	01/06/05

Amministratori	Titolo	Età	Da
Ronald Cohen CHM	Chairman	68	01/05/16
Jane Wasman BRD	Director/Board Member	67	01/05/16
Andrew Hindman BRD	Director/Board Member	51	01/12/16

Settore

	Variaz. 1 gen.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-1,51%	104 Mrd
REGENERON PHARMACEUTICALS, INC.	+3,22%	97,42 Mrd
ARGENX SE	+1,60%	22,2 Mrd
BIONTECH SE	-16,53%	21,23 Mrd
GENMAB A/S	-9,16%	18,33 Mrd
WUXI APPTEC CO., LTD.	-42,33%	16,35 Mrd
BEIGENE, LTD.	-20,09%	15,06 Mrd
NEUROCRINE BIOSCIENCES, INC.	+5,47%	13,98 Mrd
SAREPTA THERAPEUTICS, INC.	+28,85%	11,66 Mrd